A new CAR T Cell Trial is underway this month at Sarah Cannon in Nashville, TN and at MD Anderson Cancer Center in Houston, TX. This is a Phase 1 study of P-BCMA-101 autologous T stem cell memory (Tscm) CAR-T cells in patients with relapsed and/or refractory MM. Poesida Therapeutics is a San Diego-based company that [...]
This post first appeared on Page Not Found - The Myeloma Crowd, please read the originial post: here
